Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000216357 | SCV000231902 | likely benign | not specified | 2016-06-28 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000216357 | SCV000269946 | benign | not specified | 2015-11-12 | criteria provided, single submitter | clinical testing | p.Arg4493His in exon 63 of USH2A: tjhis variant is not expected to have clinical significance because it has been identified in 0.71% (61/8646) of East Asian ch romosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute. org; dbSNP rs138879998). It has been reported as a "less likely pathogenic vari ant" in an individual with retinitis pigmentosa (Xu 2014). |
Invitae | RCV000879539 | SCV001022575 | likely benign | not provided | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000879539 | SCV001147663 | likely benign | not provided | 2019-01-01 | criteria provided, single submitter | clinical testing | |
Blueprint Genetics | RCV001073767 | SCV001239327 | uncertain significance | Retinal dystrophy | 2017-12-06 | criteria provided, single submitter | clinical testing | |
Pars Genome Lab | RCV001449650 | SCV001652850 | likely benign | Usher syndrome type 2A | 2021-05-18 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000879539 | SCV001765863 | likely benign | not provided | 2021-01-29 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 29899460, 24938718) |
Dept Of Ophthalmology, |
RCV001073767 | SCV004707242 | benign | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research | |
Prevention |
RCV004537493 | SCV004730695 | likely benign | USH2A-related disorder | 2020-07-03 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |